References
- Claude Lenfant, Nikolai Khaltaev Global initiative for Chronic Obstructive Lung Disease, Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease NHLBI/WHO workshop report. 2701. 2005. National Institutes of Health, National Heart, Lung, and Blood Institute; 2001.
- Sullivan SD, Buist AS, Weiss K. Health outcomes assessment and economic evaluation in COPD: Challenges and opportunities. Eur Respir J 2003; 21: 1S–3S
- Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study. Lancet 1997; 349: 1498–1504
- Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007; 176: 532–55
- Pierson DJ. Clinical practice guidelines for chronic obstructive pulmonary disease: A review and comparison of current resources. Respir Care 2006; 51: 277–88
- BTS guidelines for the management of chronic obstructive pulmonary disease. The COPD Guidelines Group of the Standards of Care Committee of the BTS. Thorax 1997;52(Suppl 5):S1–28.
- Celli BR, Macnee W. Standards for the diagnosis and treatment of patients with COPD: A summary of the ATS/ERS position paper. Eur Respir J 2004; 23: 932–46
- Jones PW, Agusti AG. Outcomes and markers in the assessment of chronic obstructive pulmonary disease. Eur Respir J 2006; 27: 822–32
- Hardie JA, Buist AS, Vollmer WM, Ellingsen I, Bakke PS, Morkve O. Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers. Eur Respir J 2002; 20: 1117–22
- Medbo A, Melbye H. Lung function testing in the elderly: Can we still use FEV(1)/FVC < 70% as a criterion of COPD?. Respir Med 2007; 101: 1097–1105
- Pedersen F, Mehlsen J, Raymond I, Atar D, Skjoldborg US, Hildebrandt PR. Evaluation of dyspnoea in a sample of elderly subjects recruited from general practice. Int J Clin Pract 2007; 61: 1481–91
- Ries AL. Impact of chronic obstructive pulmonary disease on quality of life: The role of dyspnea. Am J Med 2006; 119: 12–20
- Chapman KR. The needs of patients with COPD can be met by more aggressive treatment of symptoms. Prim Care Resp J 2002; 11: 15–19
- Questionnaire on Respiratory Symptoms (1986) (1986). Medical Research Council; .
- Standardization of Spirometry, 1994 Update. American Thoracic Society. Am J Respir Crit Care Med 1995;152:1107–36.
- Langhammer A, Johnsen R, Gulsvik A, Holmen TL, Bjermer L. Forced spirometry reference values for Norwegian adults: The Bronchial Obstruction in Nord-Trondelag Study. Eur Respir J 2001; 18: 770–9
- Van Schayck CP, Halbert RJ, Nordyke RJ, Isonaka S, Maroni J, Nonikov D. Comparison of existing symptom-based questionnaires for identifying COPD in the general practice setting. Respirology 2005; 10: 323–33
- Vrijhoef HJ, Diederiks JP, Wesseling GJ, van Schayck CP, Spreeuwenberg C. Undiagnosed patients and patients at risk for COPD in primary health care: Early detection with the support of non-physicians. J Clin Nurs 2003; 12: 366–73
- Holleman DR, Jr, Simel DL. Does the clinical examination predict airflow limitation?. JAMA 1995; 273: 313–9
- Vandevoorde J, Verbanck S, Gijssels L, et al. Early detection of COPD: A case finding study in general practice. Respir Med 2007; 101: 525–30
- Freeman D, Nordyke RJ, Isonaka S, et al. Questions for COPD diagnostic screening in a primary care setting. Respir Med 2005; 99: 1311–18
- Salome CM, Munoz PA, Berend N, Thorpe CW, Schachter LM, King GG. Effect of obesity on breathlessness and airway responsiveness to methacholine in non-asthmatic subjects. Int J Obes 2007; 23 October [ Epub ahead of print].
- Baum CL. The effects of cigarette costs on BMI and obesity. Health Econ 2008;4 February [ Epub ahead of print].
- Calverley PM, Nordyke RJ, Halbert RJ, Isonaka S, Nonikov D. Development of a population-based screening questionnaire for COPD. COPD 2005; 2: 225–32
- Geijer RM, Sachs AP, Verheij TJ, Lammers JW, Salome PL, Hoes AW. Are patient characteristics helpful in recognizing mild COPD (GOLD I) in daily practice?. Scand J Prim Health Care 2006; 24: 237–42
- Lindberg A, Jonsson AC, Ronmark E, Lundgren R, Larsson LG, Lundback B. Ten-year cumulative incidence of COPD and risk factors for incident disease in a symptomatic cohort. Chest 2005; 127: 1544–52
- Ekberg-Aronsson M, Pehrsson K, Nilsson JA, Nilsson PM, Lofdahl CG. Mortality in GOLD stages of COPD and its dependence on symptoms of chronic bronchitis. Respir Res 2005; 6: 98
- Vestbo J, Lange P. Can GOLD Stage 0 provide information of prognostic value in chronic obstructive pulmonary disease?. Am J Respir Crit Care Med 2002; 166: 329–32